Brief: Evotec Has Taken Notice Of Statement Made By Halozyme Therapeutics Inc.
Nov 22 (Reuters) - EVOTEC SE EVTG.DE :
* HAS TAKEN NOTICE OF STATEMENT MADE BY HALOZYME
THERAPEUTICS INC.
ON 22 NOVEMBER, STATING THAT IT HAS WITHDRAWN ITS NON-BINDING
PROPOSAL TO ACQUIRE EVOTEC SE
* MANAGEMENT BOARD AND SUPERVISORY BOARD CONTINUE TO HAVE
STRONG
CONVICTION IN COMPANY'S STANDALONE STRATEGY
Source text: ID:nEQ78hCRSa
Further company coverage: EVTG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases